OpenAlex
PricingAboutJobs
Log inGet started
Work

Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial

HTML

Year: 2019
Type: article
Study design: Clinical Trial
Source: The Lancet Respiratory Medicine
DOI: 10.1016/s2213-2600(18)30420-x
Authors: Maria J Disselhorst, Josine Quispel-Janssen, Ferry Lalezari, Kim Monkhorst, Jeltje F de Vries, Vincent van der Noort, Emmy Harms, Sjaak Burgers, Paul Baas
Institution: The Netherlands Cancer Institute
Language: English

Topic: Occupational and environmental lung diseases
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: malignant pleural mesothelioma, ipilimumab, nivolumab, immune checkpoint inhibitors, CTLA-4, PD-1, combination immunotherapy, disease control, treatment-related adverse events, immune-related adverse events, platinum-refractory disease, treatment efficacy and safety
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2908887190
FWCI: 29.19
Cites: 34
Cited by: 264
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security